Spartan Bioscience Inc.

Spartan Bioscience Inc.
TrimGen

TrimGen

April 22, 2008 10:08 ET

Spartan Bioscience and TrimGen Partner to Provide End-to-End Real-Time PCR Analysis

TrimGen eQ-PCR assays and reagents optimized for the Spartan DX™ DNA analyzer

OTTAWA, ONTARIO--(Marketwire - April 22, 2008) - Spartan Bioscience Inc., a Canadian molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications, today announced a significant strategic partnership with Maryland-based TrimGen Corporation. Under an MOU (memorandum of understanding) framework between the companies, TrimGen will develop real-time PCR reagents and kits optimized to run on the Spartan DX(TM) device and Spartan will distribute TrimGen products in Canada. This will provide Spartan customers with one-stop-shopping for their on-demand real-time PCR (polymerase chain reaction) requirements.

"The Spartan DX is a new instrument for on-demand molecular diagnostics. It is fast, affordable and easy-to-use. By adding TrimGen's optimized real-time PCR assays, our customers get a complete solution for rapid DNA testing," said Dr. Paul Lem, CEO of Spartan Bioscience Inc.

"We've been working with Spartan for some time now and we share their vision of the future of on-demand real-time PCR. TrimGen's eQ-PCR reagents and kits will be represented by Spartan in Canada where they are well connected with the customers," said Dr. James Wang, CEO of TrimGen Corporation. "Spartan is creating a new market for on-demand molecular diagnostics. There is enormous potential for rapid and highly accurate DNA testing. We are very pleased with our relationship with Spartan and will continue to collaborate with them as their product line evolves."

Spartan and TrimGen will be attending the Clinical Virology Symposium in Daytona Beach, booths 110 and 111, in Florida, April 27-30, 2008

About Spartan Bioscience

Founded in 2005, Spartan Bioscience Inc. is a privately-held molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications. The company is focusing on applications where rapid and convenient DNA testing is particularly important, such as low-throughput research experiments and non-batched testing for infectious diseases.

About TrimGen Corporation

TrimGen is a privately held diagnostic company founded in 1999. The company focuses on nucleic acid-based molecular diagnosis for leukemia, cancer and infectious diseases. Our mission is to provide advanced genetic tests to transform traditional medicine into personalized medicine.

Contact Information